Join us on the Science Dispatch podcast as we discuss:
Kratom: Right to Take Risks—and the right to know what they are
Adults should be free to decide which risks they are willing to take. But what happens when those risks are poorly understood, the product's potency is uncertain, and regulators seem to offer only two choices: prohibition or permission? The controversy over kratom's potent derivative, 7-hydroxymitragynine, exposes a troubling gap between individual liberty, scientific evidence, and consumer protection.
The DEA wants to turn 7-hydroxymitragynine consumers into criminals
The DEA wants to ban concentrated kratom-derived products while leaving traditional kratom largely untouched. But is there a scientific basis for the distinction, and will prohibition protect consumers or drive them toward more dangerous alternatives?
Listen to the Science Dispatch on iTunes Spotify, Stitcher and Google Podcasts. Or add the RSS feed to your favorite podcast app. Join our Dispatch newsletter to get these stories and more delivered to your inbox.
Cameron English
Executive Vice President
Cameron English is a writer, editor and co-host of the Science Facts and Fallacies Podcast. Before joining ACSH, he was managing editor at the Genetic Literacy Project.
